Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of the Metabotropic Glutamate Receptor Subtype 5 in Circadian Rhythm Misalignment and Depression: Implications for Treatment

NCT04350567 is registered in ClinicalTrials.gov with Stony Brook University as lead sponsor.

NCT NCT04350567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04350567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of the Metabotropic Glutamate Receptor Subtype 5 in Circadian Rhythm Misalignment and Depression: Implications for Treatment
Lead sponsor
Stony Brook University
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2020
Completion date
May 31, 2025
Enrollment
61 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression; major depressive disorder